Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Equasym for ADHD completes European mutual recognition procedure

May 25, 2006

FDA approval for Ionsys transdermal analgesic system

May 25, 2006

Screening begins in phase III trial of NRP-104 for adult ADHD

May 25, 2006

Vernalis presents preclinical, clinical update on BIIB-014 for Parkinson's disease

May 24, 2006

Adenosine A2A receptor antagonist MSX-3 shows activity in parkinsonian motor effects

May 24, 2006

Unusually high placebo response rate causes failure of bicifadine phase III trial

May 24, 2006

ProEthic begins phase III study for PRO-513 for migraines

May 24, 2006

Ramelteon shows potential for circadian phase shifting

May 24, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

May 23, 2006

Recent patents cover novel analgesic agents

May 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...